Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Oct 2021. Module: SNOMED CT core module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4643393012 | Product containing precisely levamisole (as levamisole hydrochloride) 50 milligram/1 each conventional release oral tablet (clinical drug) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
| 4643394018 | Levamisole (as levamisole hydrochloride) 50 mg oral tablet | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
| 1520631000001113 | Levamisole 50mg tablets | en | Synonym | Active | Entire term case insensitive | SNOMED CT United Kingdom Edition module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing precisely levamisole (as levamisole hydrochloride) 50 milligram/1 each conventional release oral tablet (clinical drug) | Is a | Product containing only levamisole in oral dose form (medicinal product form) | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely levamisole (as levamisole hydrochloride) 50 milligram/1 each conventional release oral tablet (clinical drug) | Has manufactured dose form | Conventional release oral tablet | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely levamisole (as levamisole hydrochloride) 50 milligram/1 each conventional release oral tablet (clinical drug) | Has unit of presentation | Tablet | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely levamisole (as levamisole hydrochloride) 50 milligram/1 each conventional release oral tablet (clinical drug) | Plays role | Anthelmintic therapeutic role | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely levamisole (as levamisole hydrochloride) 50 milligram/1 each conventional release oral tablet (clinical drug) | Has precise active ingredient | Levamisole hydrochloride | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely levamisole (as levamisole hydrochloride) 50 milligram/1 each conventional release oral tablet (clinical drug) | Has basis of strength substance | Levamisole | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely levamisole (as levamisole hydrochloride) 50 milligram/1 each conventional release oral tablet (clinical drug) | Has presentation strength numerator unit | milligram | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely levamisole (as levamisole hydrochloride) 50 milligram/1 each conventional release oral tablet (clinical drug) | Has presentation strength denominator unit | Tablet | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely levamisole (as levamisole hydrochloride) 50 milligram/1 each conventional release oral tablet (clinical drug) | Has manufactured dose form | Oral dose form | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely levamisole (as levamisole hydrochloride) 50 milligram/1 each conventional release oral tablet (clinical drug) | Has NHS dm+d (dictionary of medicines and devices) dose form indicator | Discrete dose form indicator | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely levamisole (as levamisole hydrochloride) 50 milligram/1 each conventional release oral tablet (clinical drug) | Is a | Virtual medicinal product | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely levamisole (as levamisole hydrochloride) 50 milligram/1 each conventional release oral tablet (clinical drug) | Has NHS dm+d (dictionary of medicines and devices) controlled drug category | Controlled drug category No Controlled Drug Status | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely levamisole (as levamisole hydrochloride) 50 milligram/1 each conventional release oral tablet (clinical drug) | VMP non-availability indicator | Available | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely levamisole (as levamisole hydrochloride) 50 milligram/1 each conventional release oral tablet (clinical drug) | Has dispensed dose form | Tablet | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely levamisole (as levamisole hydrochloride) 50 milligram/1 each conventional release oral tablet (clinical drug) | Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) ontology form and route | tablet.oral ontology form and route | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely levamisole (as levamisole hydrochloride) 50 milligram/1 each conventional release oral tablet (clinical drug) | Has NHS dm+d (dictionary of medicines and devices) basis of strength substance | Levamisole | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely levamisole (as levamisole hydrochloride) 50 milligram/1 each conventional release oral tablet (clinical drug) | Has specific active ingredient | Levamisole hydrochloride | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely levamisole (as levamisole hydrochloride) 50 milligram/1 each conventional release oral tablet (clinical drug) | VMP prescribing status (attribute) | VMP valid as a prescribable product | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely levamisole (as levamisole hydrochloride) 50 milligram/1 each conventional release oral tablet (clinical drug) | Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) route of administration | Oral route | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely levamisole (as levamisole hydrochloride) 50 milligram/1 each conventional release oral tablet (clinical drug) | Is a | Edoxaban | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely levamisole (as levamisole hydrochloride) 50 milligram/1 each conventional release oral tablet (clinical drug) | Has disposition | Coagulation factor Xa inhibitor | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely levamisole (as levamisole hydrochloride) 50 milligram/1 each conventional release oral tablet (clinical drug) | Is a | Product containing levamisole | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely levamisole (as levamisole hydrochloride) 50 milligram/1 each conventional release oral tablet (clinical drug) | Is a | Levamisole | true | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Levamisole 50mg tablets 50 tablet | Has VMP | True | Product containing precisely levamisole (as levamisole hydrochloride) 50 milligram/1 each conventional release oral tablet (clinical drug) | Inferred relationship | Existential restriction modifier | |
| Levamisole 50mg tablets 20 tablet | Has VMP | True | Product containing precisely levamisole (as levamisole hydrochloride) 50 milligram/1 each conventional release oral tablet (clinical drug) | Inferred relationship | Existential restriction modifier | |
| Levamisole 50mg tablets 1 tablet | Has VMP | True | Product containing precisely levamisole (as levamisole hydrochloride) 50 milligram/1 each conventional release oral tablet (clinical drug) | Inferred relationship | Existential restriction modifier | |
| Ergamisol 50mg tablets (Janssen-Cilag Ltd) | Is a | True | Product containing precisely levamisole (as levamisole hydrochloride) 50 milligram/1 each conventional release oral tablet (clinical drug) | Inferred relationship | Existential restriction modifier | |
| Levamisole 50mg tablets (Part VIIID Drug Tariff Special Order) | Is a | True | Product containing precisely levamisole (as levamisole hydrochloride) 50 milligram/1 each conventional release oral tablet (clinical drug) | Inferred relationship | Existential restriction modifier | |
| Lixiana 60mg tablets (Daiichi Sankyo UK Ltd) | Has specific active ingredient | False | Product containing precisely levamisole (as levamisole hydrochloride) 50 milligram/1 each conventional release oral tablet (clinical drug) | Inferred relationship | Existential restriction modifier | |
| Edoxaban 15mg tablets | Has specific active ingredient | False | Product containing precisely levamisole (as levamisole hydrochloride) 50 milligram/1 each conventional release oral tablet (clinical drug) | Inferred relationship | Existential restriction modifier | |
| Edoxaban 15mg tablets 10 tablet | Has specific active ingredient | False | Product containing precisely levamisole (as levamisole hydrochloride) 50 milligram/1 each conventional release oral tablet (clinical drug) | Inferred relationship | Existential restriction modifier | |
| Edoxaban 30mg tablets 28 tablet | Has specific active ingredient | False | Product containing precisely levamisole (as levamisole hydrochloride) 50 milligram/1 each conventional release oral tablet (clinical drug) | Inferred relationship | Existential restriction modifier | |
| Lixiana 30mg tablets (Pharmaram Ltd) 30 tablet | Has specific active ingredient | False | Product containing precisely levamisole (as levamisole hydrochloride) 50 milligram/1 each conventional release oral tablet (clinical drug) | Inferred relationship | Existential restriction modifier | |
| Lixiana 30mg tablets (Daiichi Sankyo UK Ltd) | Has specific active ingredient | False | Product containing precisely levamisole (as levamisole hydrochloride) 50 milligram/1 each conventional release oral tablet (clinical drug) | Inferred relationship | Existential restriction modifier | |
| Edoxaban 30mg tablets 30 tablet | Has specific active ingredient | False | Product containing precisely levamisole (as levamisole hydrochloride) 50 milligram/1 each conventional release oral tablet (clinical drug) | Inferred relationship | Existential restriction modifier | |
| Lixiana 60mg tablets (Daiichi Sankyo UK Ltd) 28 tablet 2 x 14 tablets | Has specific active ingredient | False | Product containing precisely levamisole (as levamisole hydrochloride) 50 milligram/1 each conventional release oral tablet (clinical drug) | Inferred relationship | Existential restriction modifier | |
| Edoxaban 30mg tablets | Has specific active ingredient | False | Product containing precisely levamisole (as levamisole hydrochloride) 50 milligram/1 each conventional release oral tablet (clinical drug) | Inferred relationship | Existential restriction modifier | |
| Lixiana 30mg tablets (Pharmaram Ltd) | Has specific active ingredient | False | Product containing precisely levamisole (as levamisole hydrochloride) 50 milligram/1 each conventional release oral tablet (clinical drug) | Inferred relationship | Existential restriction modifier | |
| Lixiana 15mg tablets (Daiichi Sankyo UK Ltd) 10 tablet | Has specific active ingredient | False | Product containing precisely levamisole (as levamisole hydrochloride) 50 milligram/1 each conventional release oral tablet (clinical drug) | Inferred relationship | Existential restriction modifier | |
| Edoxaban 60mg tablets 28 tablet | Has specific active ingredient | False | Product containing precisely levamisole (as levamisole hydrochloride) 50 milligram/1 each conventional release oral tablet (clinical drug) | Inferred relationship | Existential restriction modifier | |
| Edoxaban 60mg tablets 30 tablet | Has specific active ingredient | False | Product containing precisely levamisole (as levamisole hydrochloride) 50 milligram/1 each conventional release oral tablet (clinical drug) | Inferred relationship | Existential restriction modifier | |
| Lixiana 60mg tablets (Pharmaram Ltd) 30 tablet | Has specific active ingredient | False | Product containing precisely levamisole (as levamisole hydrochloride) 50 milligram/1 each conventional release oral tablet (clinical drug) | Inferred relationship | Existential restriction modifier | |
| Edoxaban 60mg tablets | Has specific active ingredient | False | Product containing precisely levamisole (as levamisole hydrochloride) 50 milligram/1 each conventional release oral tablet (clinical drug) | Inferred relationship | Existential restriction modifier | |
| Lixiana 15mg tablets (Daiichi Sankyo UK Ltd) | Has specific active ingredient | False | Product containing precisely levamisole (as levamisole hydrochloride) 50 milligram/1 each conventional release oral tablet (clinical drug) | Inferred relationship | Existential restriction modifier | |
| Lixiana 60mg tablets (Pharmaram Ltd) | Has specific active ingredient | False | Product containing precisely levamisole (as levamisole hydrochloride) 50 milligram/1 each conventional release oral tablet (clinical drug) | Inferred relationship | Existential restriction modifier | |
| Lixiana 30mg tablets (Daiichi Sankyo UK Ltd) 28 tablet 2 x 14 tablets | Has specific active ingredient | False | Product containing precisely levamisole (as levamisole hydrochloride) 50 milligram/1 each conventional release oral tablet (clinical drug) | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR